tiprankstipranks
Genflow Biosciences Plc (GB:GENF)
LSE:GENF

Genflow Biosciences Plc (GENF) Share Price & Analysis

5 Followers

GENF Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range1.32p - 3.41p
Previous Close2.25p
Volume51.76K
Average Volume (3M)1.23M
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)£683.97K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)
Beta0.16
Sep 27, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume1,232,066
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

36.82%0.00%0.00%63.18%
36.82% Insiders
0.00% Other Institutional Investors
63.18% Public Companies and
Individual Investors

GENF FAQ

What was Genflow Biosciences Plc’s price range in the past 12 months?
Genflow Biosciences Plc lowest share price was 1.32p and its highest was 3.41p in the past 12 months.
    What is Genflow Biosciences Plc’s market cap?
    Currently, no data Available
    When is Genflow Biosciences Plc’s upcoming earnings report date?
    Genflow Biosciences Plc’s upcoming earnings report date is Sep 27, 2024 which is in 71 days.
      How were Genflow Biosciences Plc’s earnings last quarter?
      Genflow Biosciences Plc released its earnings results on May 07, 2024. The company reported -0.003p earnings per share for the quarter, missing the consensus estimate of N/A by -0.003p.
        Is Genflow Biosciences Plc overvalued?
        According to Wall Street analysts Genflow Biosciences Plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Genflow Biosciences Plc pay dividends?
          Genflow Biosciences Plc does not currently pay dividends.
          What is Genflow Biosciences Plc’s EPS estimate?
          Genflow Biosciences Plc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Genflow Biosciences Plc have?
          Genflow Biosciences Plc has 349,706,600 shares outstanding.
            What happened to Genflow Biosciences Plc’s price movement after its last earnings report?
            Genflow Biosciences Plc reported an EPS of -0.003p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Genflow Biosciences Plc?
              Currently, no hedge funds are holding shares in GB:GENF
              ---

              Genflow Biosciences Plc Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              0.00%
              12-Months-Change

              Fundamentals

              Return on Equity
              -105.34%
              Trailing 12-Months
              Asset Growth
              -59.06%
              Trailing 12-Months

              Company Description

              Genflow Biosciences Plc

              Genflow Biosciences PLC is focused on longevity and the development of therapies to counteract the effects of ageing and diseases associated with advanced age.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Genedrive
              Genus plc
              HemoGenyx Pharmaceuticals Plc
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis